DNOPY yields 22.12% · JNJ yields 2.14%● Live data
📍 DNOPY pulled ahead of the other in Year 1
Combined, DNOPY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DNOPY + JNJ for your $10,000?
Dino Polska S.A., together with its subsidiaries, operates a chain of mid-sized grocery supermarkets under the Dino name in Poland. The company offers range of food products, including meat, poultry and cold cuts, fruit and vegetables, bread, and dairy products, as well as other food, chemical, and cosmetic products; grocery products, such as children's food, breakfast products, ready to eat meals, beverages, candies, snacks, frozen goods, processed goods, oils, grain and bulk products, condiments, and alcohol and cigarettes; and non-grocery products, which include flowers, cleaning agents, sanitary articles, pet food, and small household appliance products. It is also involved in producing, processing, and preserving of meat products; renting and operating of own or leased real estate; private purchase and sale of real estate; manufacturing and processing of refined petroleum products; and retail sale of automotive fuels, as well as provision of warehousing and storage, and financial services. As of June 30, 2022, the company operated 1,975 stores. Dino Polska S.A. was founded in 2007 and is based in Krotoszyn, Poland.
Full DNOPY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.